Whole-genome sequencing of bacteria has recently emerged as a cost-effective and convenient
approach for addressing many microbiological questions. Here, we review the current …

Background Before the emergence of the B.1.617.2 (delta) variant of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), vaccination reduced transmission of SARS-CoV-2 …

Over the last 20 years there have been 32 reports of carbapenem-resistant organisms in the
hospital water environment, with half of these occurring since 2010. The majority of these …

Background The relationship between the presence of antibodies to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains …

The effectiveness of the BNT162b2 and ChAdOx1 vaccines against new severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re-evaluation, …

Background Tuberculosis incidence in the UK has risen in the past decade. Disease control
depends on epidemiological data, which can be difficult to obtain. Whole-genome …

The effectiveness of COVID-19 vaccination in preventing new severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infections in the general community is still unclear. Here, …

We report that in a cohort of 45,965 adults, who were receiving either the ChAdOx1 or the
BNT162b2 SARS-CoV-2 vaccines, in those who had no prior infection with SARS-CoV-2, …

Background It has been thought that Clostridium difficile infection is transmitted predominantly
within health care settings. However, endemic spread has hampered identification of …

Background Diagnosing drug-resistance remains an obstacle to the elimination of tuberculosis.
Phenotypic drug-susceptibility testing is slow and expensive, and commercial genotypic …